Analyses / Public Summary / 119 · HRES 1295 Public Summary

119-HRES-1295 Journalist Public Summary

119 · HRES 1295 Expressing support for the designation of May 17, 2026, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.

A bipartisan House resolution to recognize May 17, 2026 as DIPG Awareness Day, spotlighting a deadly pediatric brain tumor and urging greater research attention; it is nonbinding and currently in the House Energy and Commerce Committee.

Published
18 May 2026
Updated
18 May 2026
Tags
DIPG · House Resolution · Pediatric Cancer
Unvetted
01 · Section

Public Summary

Headline Summary: A bipartisan House resolution backs “DIPG Awareness Day” on May 17, 2026, to draw attention to a lethal childhood brain cancer and encourage more research focus.

What It Does: The measure expresses the House’s support for designating May 17, 2026, as DIPG Awareness Day. It highlights the disease’s severe outcomes for children and urges expanded research and for funders to weigh mortality and life‑years lost more heavily in pediatric cancer grants. It is a statement of support, not a change to law or spending.

Children affected annually (est.)
300children/yr
Median survival after diagnosis
9months
Five-year survival rate
1%
Estimated life‑years lost annually
24000years
  • Primary sponsors: Rep. Debbie Dingell (D‑MI), Rep. Michael McCaul (R‑TX), and Rep. Dave Joyce (R‑OH), signaling bipartisan backing.
  • Pediatric cancer advocates and families seeking faster progress on hard‑to‑treat brain tumors.
  • Members who emphasize rare‑disease research and visibility efforts.
  • No formal, organized opposition is evident for this type of commemorative resolution.
  • Skeptics sometimes argue symbolic measures have limited practical effect and prefer direct funding or policy changes instead.

What’s Next: Introduced and referred to the House Committee on Energy and Commerce on May 15, 2026. As a simple House resolution, if the committee advances it and the House adopts it, it becomes the chamber’s official position; it does not go to the Senate or the President.

Discussion